A 5-HT Antagonist (UP 26-91) versus Codeine and Placebo in a Human Experimental Pain Study
BACKGROUND: This double-blind, randomized, crossover study compared the potential analgesic effect of the serotonin receptor antagonist UP 26-91 (50 mg, 150 mg and 300 mg) with that of codeine (100 mg) and placebo by use of different human experimental pain models.
Main Authors: | Lars Arendt-Nielsen, Poul Pedersen, Lars Poulsen, Ole Kæseler Andersen, Peter Bjerring, Isabelle Coste, Jorge Insuasty, Søren Sindrup, Asbjørn Mohr Drewes |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2000-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2000/842198 |
Similar Items
-
5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
by: Neyousha Mohammadi, et al.
Published: (2010-01-01) -
5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
by: Neyousha Mohammadi, et al.
Published: (2010-01-01) -
The role of serotonin (5HT) and 5HT antagonists in urological cancers
by: Siddiqui, Emad Jawed
Published: (2007) -
Synthesis of Selective 5-HT6 and 5-HT7 Receptor Antagonists
by: Raux, Elizabeth A
Published: (2010) -
Synthesis of Selective 5-HT6 and 5-HT7 Receptor Antagonists
by: Raux, Elizabeth A
Published: (2010)